The in vivo and in vitro effects of an alkylating agent, mechlorethamine, on IL-6 production in mice and the role of macrophages

Immunopharmacology

Volumn 34, Issue 2-3, 1996, Pages 73-78

  Bryniarski, Krzysztof ^a   Ptak, Maria ^a   Ptak, Włodzimierz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cyclophosphamide; IL 6; Macropages; Mechlorethamine

Indexed keywords

ALKYLATING AGENT; CHLORMETHINE; CYCLOPHOSPHAMIDE; DRUG METABOLITE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; NITRITE; PARAFFIN; THIOGLYCOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA CROSS LINKING; DRUG MECHANISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030248178     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(96)00130-0     Document Type: Article

References (21)

1. Askenase P.W., Hayden, B.J. and Gershon, R.K., 1975. Augmentation of delayed-type hyper-sensitivity by doses of cytoxan which do not affect antibody responses. J. Exp. Med. 141: 697-702.
2. Ding, A.H., Nathan, C.F. and Stuchr, D.J., 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141: 2417-2419.
3. Duclos, H., Galanaud, P., Devinsky, O., Maillot, M.C. and Dormont, J., 1977. Enhancing effect of low dose cyclophosphamide treatment on the in vitro antibody response. Eur. J. Immunol. 7: 679-684.
4. Hemminki, K., 1985. Binding of metabolites of cyclophosphamide to DNA in rat liver microsomal system and in vivo in mice. Cancer Res. 45: 4237-4243.
5. Hirano, T., Akira, S., Taga, T. and Kishimoto, T., 1990. Biological and clinical aspects of interleukin 6. lmmunol. Today 11: 443-449.
6. Kishimoto, T., Akira, S. and Taga, T., 1992. Interleukin-6 and its receptor: a paradigm for cytokines. Science 258: 593-597.
7. Kishimoto, T., Taga, T. and Akira, S., 1994. Cytokine signal transduction. Cell 76: 253-262.
8. L'Age-Stehr, J. and Diamantstein, T., 1978. Induction of autoreactive T lymphocytes and their suppressor cells by cyclophosphamide. Nature (London) 241: 663-665.
9. Luger, T.A., Krtmann, J., Kirnbauer, R., Urbanski, A., Schwarz, T., Klappacher, G., Kock, A., Micksche, M., Malejczyk, J., Schauer, E., May, L.T. and Sehgal, P.B., 1989. IFNβ2/IL-6 augments the activity of human natural killer cells. J. Immunol. 143: 1206-1209.
10. Marcinkiewicz, J., 1991. In vitro cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of TNFα, IL-1 and IL-6. Cytokine 3: 327-332.
11. Marcinkiewicz, J., Bryniarski, K. and Ptak, W., 1994. Cyclophosphamide uncovers two separate macrophage subpopulations with opposite immunogenic potential and different patterns of monokine productin. Cytokine 6: 472-477.
12. Marinello, A., Bansal, S.K., Koser, P.L., Love, J., Struck, R.F. and Gurtoo, H.L., 1984. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal Cytochrome P-480. Cancer Res. 44: 4615-462.
13. Mastrangelo, M.J., Berd, D. and Maguire, H., 1986. The immunoaugmenting effects of cancer chemotherapeutic agents. Sem. Oncol. 13: 186-194.
14. Moore, M.J., 1991. Clinical pharmakokinetics of cyclophosphamide. Clin. Pharmakokinet. 20: 194-208.
15. Paul, R.D., Ghaffer, A. and Sigal, M.M., 1982. Selective action of alkylating agents against cells participating in suppression of antibody responses. Int. J. Immunopharmacol. 4: 159-166.
16. Sehgal, P., 1990, Interleukin-6: A regulator of plasma protein gene expression in hepatic and non-hepatic tissues. Mol. Biol. Med. 7: 117-130.
17. Sikic, B., 1982. Antineoplastic agents. In: eds. C.C. Craig and R.E. Stitzel, Modern Pharmacology, Little, Brown Boston, pp. 757-790.
18. Szczepanik, M., Bryniarski, K., Pryjma, J. and Ptak, W., 1993. Distinct populations of antigen-presenting macrophages are required for induction of effector and regulatory cells in contact sensitivity response in mice. J. Leuk. Biol. 53: 320-326.
19. Tada, H., Shiho, O., Kuroshima, K., Koyoma, M. and Tsukamoto, K., 1986. An improved colorimetric assay for interleukin-2. J. Immunol. Meth. 93: 157-161.
20. Winstanley, F.P. and Eckersall, P.D., 1992. Biossay of bovine interleukin-1 like activity. Res. Vet. Sci. 52: 273-276.
21. Wolvekamp, M.C.J. and Marquet, R.L., 1990. Interleukin-6: historical background, genetics and biological significance. Immunol. Lett. 24: 1-10.